CHOLANGITIS SCLEROSING

This adverse event was reported 2056 times

These drugs are most commonly taken by patients reporting CHOLANGITIS SCLEROSING:

# Drug Count
0 ADALIMUMAB 271
1 VEDOLIZUMAB 258
2 INFLIXIMAB 240
3 PREDNISONE 212
4 NIVOLUMAB 179
5 PEMBROLIZUMAB 176
6 DOXYCYCLINE HYCLATE 135
7 DOXYCYCLINE 126
8 AZATHIOPRINE 117
9 METHOTREXATE SODIUM 113
See all common drugs associated with CHOLANGITIS SCLEROSING

CHOLANGITIS SCLEROSING is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 STREPTOZOCIN 5 0.0217
1 LINERIXIBAT 1 0.0175
2 OLSALAZINE SODIUM 3 0.0152
3 MEDICATED HEMORRHOIDAL WIPES 1 0.0115
4 INFLIXIMAB-DYYB 27 0.0078
5 KETAMINE HYDROCHLORIDE 35 0.0068
6 FERRIC DERISOMALTOSE 9 0.0066
7 ERYTHROMYCIN AND BENZOYL PEROXIDE 1 0.0062
8 CYCLOPENTOLATE HYDROCHLORIDE 4 0.0061
9 NALDEMEDINE 10 0.0060
See all drugs enriched for association with CHOLANGITIS SCLEROSING